# Exploratory Evaluation of [11C]MPC6827

> **NCT04575727** · EARLY_PHASE1 · COMPLETED · sponsor: **Columbia University** · enrollment: 17 (actual)

## Conditions studied

- Neurodegenerative Diseases
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** [11C]MPC6827

## Key facts

- **NCT ID:** NCT04575727
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-08
- **Primary completion:** 2024-06-21
- **Final completion:** 2024-06-21
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04575727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04575727, "Exploratory Evaluation of [11C]MPC6827". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04575727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*